Alan Meds vs PauseRX
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
PauseRX
Best for Buyers who value **supply-chain transparency** — PauseRX's explicit disclosure of the 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) + physician network (Beluga Health) + corporate entity (PauseRX, Inc.) is significantly above the typical DTC GLP-1 platform floor and lets buyers independently verify the clinical and dispensing pipeline. Strong fit for buyers comfortable with cash-pay (no insurance), async telehealth, and the restrictive no-cancellation policy. NOT a menopause-specific platform despite the brand name — buyers seeking that focus should look at Alloy, Midi Health, or Hers Menopause.Starting at $199/mo
Side-by-Side Comparison
| Feature | Alan Meds | PauseRX |
|---|---|---|
| Overall Score | ✓7.7/10 | 6.5/10 |
| Starting Price | ✓$99/mo | $199/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.3 ★ /5 |
| Features | 5 features | ✓12 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
PauseRX
Pros
- ✓**Explicit 503A pharmacy partner disclosure (Strive Pharmacy, Gilbert AZ 85233)** — genuinely uncommon. Buyers can independently verify Strive Pharmacy's licensure + 503A status. Removes the typical DTC marketplace abstraction.
- ✓**Explicit physician-network disclosure (Beluga Health)** — buyers can research the clinical platform handling their prescriptions. Significantly above the 'certified healthcare providers' generic-language floor.
- ✓**Verbatim FDA compounded-medication disclaimer published** — meets WLR transparency standard for compounded-product communication
- ✓**Corporate legal entity disclosed (PauseRX, Inc.)** — uncommon for DTC GLP-1 platforms
- ✓$199 flat 'all doses' compounded sema pricing removes per-tier escalation
- ✓Billing at ship (not at order) reduces upfront cash exposure
- ✓LegitScript badge displayed (verification posture present even if ID not numbered in FAQ)
- ✓Adjunct longevity products (NAD+, Glutathione, Sermorelin) for buyers seeking broader wellness stack within one platform
Cons
- ✗**State-by-state coverage list NOT enumerated** — site claims nationwide but specific state availability requires contacting support
- ✗**Cancellation policy is restrictive: 'unable to change or cancel once submitted. Medications are not able to be returned or exchanged.'** — buyers who change their mind after placing an order have no recourse
- ✗**Named medical director / clinical lead NOT disclosed** by name despite Beluga Health network disclosure (Beluga is the network, not a named MD)
- ✗**LegitScript ID NUMBER not specified in FAQ** — badge is displayed but the verifiable certification number is not surfaced, preventing direct lookup
- ✗Insurance NOT accepted — cash-pay only
- ✗HSA/FSA eligibility NOT confirmed in FAQ
- ✗Corporate physical address NOT provided (only Strive Pharmacy + Beluga Health addresses)
- ✗Despite the 'Pause' brand name, the platform is NOT formally positioned as menopause/perimenopause-specific — buyers seeking menopause-focused clinical care should look at dedicated menopause platforms
- ✗Brand Wegovy + Zepbound + Foundayo are 'consultations' (not direct dispensing) — fulfillment depends on the brand-drug supply chain elsewhere
Our Verdict
Alan Meds edges out PauseRX with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. PauseRX remains a solid alternative, especially if you're looking for Buyers who value **supply-chain transparency** — PauseRX's explicit disclosure of the 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) + physician network (Beluga Health) + corporate entity (PauseRX, Inc.) is significantly above the typical DTC GLP-1 platform floor and lets buyers independently verify the clinical and dispensing pipeline. Strong fit for buyers comfortable with cash-pay (no insurance), async telehealth, and the restrictive no-cancellation policy. NOT a menopause-specific platform despite the brand name — buyers seeking that focus should look at Alloy, Midi Health, or Hers Menopause..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.